Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

AGA risk factors include age, smoking, hypertension for men, and age, dyslipidemia for women; lifestyle changes may help prevention.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

More research is needed to understand hair and scalp disorders in people with skin of color.

The document is a detailed guide on skin conditions and treatments for dermatologists.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Both treatments for pemphigus foliaceus in dogs are effective, but combination therapy has more side effects.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

The document concludes that early diagnosis and treatment are crucial for children with hair loss to prevent permanent damage, although not all conditions can be effectively treated.

The regenerative solution, tSVF, is a safe and effective treatment for various conditions like aged skin, scars, wounds, and more, but more research is needed to find the best way to use it.

Spironolactone harms fish reproduction and is more potent in fish than invertebrates, needing environmental monitoring.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The study aims to find the best treatment for central serous chorioretinopathy by comparing various options.

Dogs with generalized discoid lupus erythematosus have similar symptoms to humans and need continuous treatment.

Two patients with skin lupus were mistakenly thought to have a different scalp condition but improved with lupus treatment.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Obese mice with a leptin gene mutation have a longer resting phase in their hair cycle, which may help understand certain hair loss conditions.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.